Sanofi bucks unit-sale trend with plan to unload $7B worth of older products

Sanofi CEO Chris Viehbacher

While other companies are hiving off large pieces of their operations to get fit and focused, Sanofi ($SNY) has decided to simply clean out its closet. By selling off a number of older products, it can make room for the kind of bolt-on deals that CEO Chris Viehbacher said on Tuesday interest him. Report

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

Telehealth is surging during the pandemic, however, pharma companies’ place in the booming practice is still emerging.

Merck is expanding its cancer awareness effort with journalist Katie Couric to include survivorship and screening topics and a new podcast next month.